PUBLISHER: TechNavio | PRODUCT CODE: 1714145
PUBLISHER: TechNavio | PRODUCT CODE: 1714145
The female sexual dysfunction treatment market is forecasted to grow by USD 42824.6 mn during 2024-2029, accelerating at a CAGR of 62.2% during the forecast period. The report on the female sexual dysfunction treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, growing awareness of female sexual dysfunction, and approval and availability of drugs to treat hypoactive sexual desire disorder.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 42.4% |
CAGR | 62.2% |
Incremental Value | $42824.6 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's female sexual dysfunction treatment market is segmented as below:
By Age Group
By Product
By Route Of Administration
By Distribution Channel
By Geographical Landscape
This study identifies the increasing research and development for treatment of sexual dysfunction in women as one of the prime reasons driving the female sexual dysfunction treatment market growth during the next few years. Also, safety label changes for female sexual dysfunction therapy and increasing use of drugs causing sexual dysfunction in women will lead to sizable demand in the market.
The report on the female sexual dysfunction treatment market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading female sexual dysfunction treatment market vendors that include AbbVie Inc., Covis Pharma GmbH, Novo Nordisk AS, Palatin Technologies Inc., Sprout Pharmaceuticals Inc., and TherapeuticsMD. Also, the female sexual dysfunction treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: